Search results for "europea"

showing 10 items of 3672 documents

Stressing the Importance of Adult Immunization: Suggestions for How to Change the Paradigm

2019

From 24 to 26 May 2017, the European Interdisciplinary Council on Ageing (EICA) and the European Union Geriatric Medicine Society (EUGMS) brought together a group of key opinion leaders and stakeholders from the healthcare field, for a conference entitled “Changing the Paradigm: Stressing the Importance of Adult Immunization”. The specific objectives of this meeting were to review vaccine-preventable diseases (VPDs) and vaccine performance in older adults and analyse the impact of the adult vaccination campaigns currently being implemented in Europe. The meeting aimed to improve our understanding of the challenge that vaccine hesitancy or scepticism represents, and how existing barriers to …

medicine.medical_specialtybusiness.industryPublic healthOpinion leadershipPharmacyPublic relationsOne HealthHealth promotionAction planPolitical scienceHealth caremedicinemedia_common.cataloged_instanceEuropean unionbusinessmedia_common
researchProduct

Establishing cut-off values for apolipoprotein B and non-HDL-C according to LDL-C values in a South European population

2012

SUMMARY Background: Low-density lipoprotein cholesterol (LDL-C) remains the primary target of therapy in most strategies of dyslipidaemia management focused on cardiovascular disease prevention. Different guidelines have identified specific LDL-C cut-off points as targets for therapeutic intervention. Many clinical situations characterised by dyslipidaemia and elevated triglycerides are common in our environment and in overall industrialised countries. Thus, lipid goals based only on LDL-C could misclassify an important percentage of subjects. The objective of the present study was to establish cut-off point values for apoB and non-HDL-C in relation to the identified LDL-C cut-off points fo…

medicine.medical_specialtyeducation.field_of_studyApolipoprotein BbiologyCross-sectional studybusiness.industryCholesterolNon hdl cPopulationnutritional and metabolic diseasesGeneral MedicineEuropean populationchemistry.chemical_compoundEndocrinologychemistryInternal medicinemedicinebiology.proteinlipids (amino acids peptides and proteins)Young adultbusinesseducationLipoprotein cholesterolInternational Journal of Clinical Practice
researchProduct

P-0023 Gastric Cancer in Latvia in 1980 – 2010

2012

ABSTRACT Introduction According to GLOBOCAN 2008 data gastric cancer currently is the fourth most common cancer worldwide and the second most common cause of cancer death. The objective of this study was to get comparable data on gastric cancer for 30 years period, to analyze the trends of incidence and mortality in Latvia and to compare with situation in other countries. Methods Incidence and mortality data from 1980 to 2010 in Latvia were obtained from the National Health Service. IARC (GLOBOCAN 2008) database was used for international comparisons. Incidence and mortality rates were age standardized to the World Standard Population and expressed per 100,000 population. Results There were…

medicine.medical_specialtyeducation.field_of_studyStandard Populationbusiness.industryMortality rateIncidence (epidemiology)PopulationCancerHematologyStage iimedicine.diseaseOncologyInternal medicineMedicinemedia_common.cataloged_instanceEuropean unionStage (cooking)businesseducationmedia_commonAnnals of Oncology
researchProduct

Triglycerides, HDL cholesterol and atherogenic dyslipidaemia in the 2019 European guidelines for the management of dyslipidaemias.

2019

In general, both European and American clinical guidelines have addressed the management of atherogenic dyslipidaemia in an unconvincing and even superficial way, largely because of the available therapeutic limitations. Consequently, this type of dyslipidaemia is underdiagnosed, under-treated, and under-controlled. Given the recent presentation of the 2019 guidelines of the European Atherosclerosis Society and the European Society of Cardiology on the management of dyslipidaemias, it seems appropriate to examine its position with respect to atherogenic dyslipidaemia and/or its main components, the increase in triglyceride-rich lipoproteins, and the decrease of high-density lipoprotein chol…

medicine.medical_specialtyendocrine system diseaseschemistry.chemical_compoundTriglycerides/HDL CholesterolInternal medicineMedicineHumanscardiovascular diseasesTriglyceridesGeneral Environmental ScienceLipoprotein cholesterolDyslipidemiasbusiness.industryCholesterolCholesterol HDLGeneral Engineeringnutritional and metabolic diseasesAtherosclerosisEuropechemistryPractice Guidelines as TopicCardiologyEuropean atherosclerosis societyGeneral Earth and Planetary Scienceslipids (amino acids peptides and proteins)businessClinica e investigacion en arteriosclerosis : publicacion oficial de la Sociedad Espanola de Arteriosclerosis
researchProduct

First-Episode Psychotic Patients Showed Longitudinal Brain Changes Using fMRI With an Emotional Auditory Paradigm

2020

[EN] Most previous longitudinal studies of functional magnetic resonance imaging (fMRI) in first-episode psychosis (FEP) using cognitive paradigm task found an increased activation after antipsychotic medications. We designed an emotional auditory paradigm to explore brain activation during emotional and nonemotional word processing. This study aimed to analyze if longitudinal changes in brain fMRI BOLD activation is present in patients vs. healthy controls. A group of FEP patients (n = 34) received clinical assessment and had a fMRI scan at baseline and follow-up (average, 25-month interval). During the fMRI scan, both emotional and nonemotional words were presented as a block design. Resu…

medicine.medical_specialtylcsh:RC435-57103 medical and health sciences0302 clinical medicinefMRI—functional magnetic resonance imaginglcsh:PsychiatryFirst episode psychosis (FEP)medicinemedia_common.cataloged_instancePsiquiatriaEuropean unionPsychiatryOriginal Researchmedia_commonPsychiatryFirst episodeFMRI-functional magnetic resonance imagingFollow upParadigmEmotional design model030227 psychiatryPsychiatry and Mental healthnervous systemLongitudinalPsychologyLENGUAJES Y SISTEMAS INFORMATICOS030217 neurology & neurosurgeryFrontiers in Psychiatry
researchProduct

Oxidative Stress and Ubiquitin Ligases: their involvement in skeletal muscle atrophy

2015

Introduction Muscle atrophy plays a relevant role in the many very prevalent diseases. Generation of reactive oxygen species (mainly by the xanthine oxidase) and inflammation are two of the main triggers of muscle atrophy. Aim The major aim of our study was to determine the mechanism by which reactive oxygen species activate E3 ubiquitin ligases (MuRF-1 and MAFbx) cause muscle atrophy. Possible prevention by allopurinol, a well-known xanthine oxidase inhibitor widely used in clinical practice; and by indomethacin, a non-steroidal antiinflamatory drug was also studied. Materials and methods Male C57BL/6J mice (3 months old) conditioned by 14 days of hindlimb unloading with or without each tr…

medicine.medical_specialtymedicine.drug_classAllopurinolBiologymedicine.diseaseBiochemistryMuscle atrophyCachexiachemistry.chemical_compoundEndocrinologyAtrophychemistryPhysiology (medical)SarcopeniaInternal medicinemedicinemedia_common.cataloged_instanceEuropean unionmedicine.symptomXanthine oxidaseXanthine oxidase inhibitormedia_commonmedicine.drugFree Radical Biology and Medicine
researchProduct

Source strength determination in iridium-192 and cobalt-60 brachytherapy : A European survey on the level of agreement between clinical measurements …

2021

Background and purpose: Brachytherapy treatment outcomes depend on the accuracy of the delivered dose distribution, which is proportional to the reference air-kerma rate (RAKR). Current societal recommendations require the medical physicist to compare the measured RAKR values to the manufacturer source calibration certificate. The purpose of this work was to report agreement observed in current clinical practice in the European Union. Materials and methods: A European survey was performed for high- and pulsed-dose-rate (HDR and PDR) highenergy sources (Ir-192 and Co-60), to quantify observed RAKR differences. Medical physicists at eighteen hospitals from eight European countries were contac…

medicine.medical_specialtymedicine.medical_treatmentBrachytherapyTreatment outcomeBrachytherapyR895-920HDRDose distributionMedical physicistMedical physics. Medical radiology. Nuclear medicinePDRmedicinemedia_common.cataloged_instanceRadiology Nuclear Medicine and imagingMedical physicsOriginal Research ArticleEuropean unionRC254-282media_commonRadiationCobalt 60 brachytherapybusiness.industryRAKRNeoplasms. Tumors. Oncology. Including cancer and carcinogensCertificateSource strengthCalibrationRadiologi och bildbehandlingbusinessRAKR; Calibration; HDR; PDR; BrachytherapyRadiology Nuclear Medicine and Medical Imaging
researchProduct

The EHA research roadmap

2021

International audience; In 2016, the European Hematology Association (EHA) published the EHA Roadmap for European Hematology Research(1) aiming to highlight achievements in the diagnostics and treatment of blood disorders, and to better inform European policy makers and other stakeholders about the urgent clinical and scientific needs and priorities in the field of hematology. Each section was coordinated by 1-2 section editors who were leading international experts in the field. In the 5 years that have followed, advances in the field of hematology have been plentiful. As such, EHA is pleased to present an updated Research Roadmap, now including 11 sections, each of which will be published…

medicine.medical_specialtymedicine.medical_treatmentPlatelet disorderClinical scienceHematopoietic stem cell transplantation030204 cardiovascular system & hematology03 medical and health sciences0302 clinical medicineInternal medicinemedicineDiseases of the blood and blood-forming organsIntensive care medicine030304 developmental biology0303 health sciencesHematologybusiness.industryTransfusion medicineHematologyHemostatic Disorders3. Good healthBlood DisorderEuropean policy[SDV.SPEE] Life Sciences [q-bio]/Santé publique et épidémiologiePerspective[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologieRC633-647.5businessHemaSphere
researchProduct

Prevention, diagnosis and treatment of venous thromboembolism

2020

Machaj Dominik, Cyboran Katarzyna, Płaczek Alicja, Baran Marlena, Wojnowski Michał. Prevention, diagnosis and treatment of venous thromboembolism. Journal of Education, Health and Sport. 2020;10(6):88-94. eISSN 2391-8306. DOI http://dx.doi.org/10.12775/JEHS.2020.10.06.009 https://apcz.umk.pl/czasopisma/index.php/JEHS/article/view/JEHS.2020.10.06.009 https://zenodo.org/record/3889858 The journal has had 5 points in Ministry of Science and Higher Education parametric evaluation. § 8. 2) and § 12. 1. 2) 22.02.2019. © The Authors 2020; This article is published with open access at Licensee Open Journal Systems of Nicolaus Copernicus University in Torun, Poland Ope…

medicine.medical_specialtypulmonary embolismDeep veinvenous thromboembolismLumen (anatomy)Thrombophiliadeep vein thrombosisEducationmedicinemedia_common.cataloged_instancecardiovascular diseasesThrombusEuropean unionVeinmedia_commonbusiness.industryRmedicine.diseaseLThrombosisSurgeryPulmonary embolismmedicine.anatomical_structureGV557-1198.995MedicinebusinessSportsJournal of Education, Health and Sport
researchProduct

A Non-Interventional Study of Tiotropium/Olodaterol versus Any Triple Combination Therapy for Chronic Obstructive Pulmonary Disease: The EVELUT® Stud…

2020

Roland Buhl,1 Michael Dreher,2 Stephanie Korn,1 Christian Taube,3 Christian Stock,4 Christoph M Zehendner,5 Anke Kondla,5 Claus F Vogelmeier6 1Pulmonary Department, Johannes Gutenberg University Mainz, Mainz, Germany; 2Clinic of Cardiology, Pneumology, Angiology and Internal Medicine Intensive Care, University Hospital RWTH Aachen, Aachen, Germany; 3Clinic for Pneumonology, University Medicine Essen – Ruhrlandklinik, Essen, Germany; 4Biostatistics + Data Sciences Corp, Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim am Rhein, Germany; 5HP Country Medical Affairs, Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim am Rhein, Germany; 6Department of Pneumology,…

medicine.medical_specialtytiotropium/olodaterolMedizinMuscarinic AntagonistsInternational Journal of Chronic Obstructive Pulmonary Disease03 medical and health scienceschemistry.chemical_compoundStudy ProtocolPulmonary Disease Chronic Obstructive0302 clinical medicineMaintenance therapySpiolto® Respimat®Internal medicineAdministration Inhalationmedicinemedia_common.cataloged_instanceCOPDHumansMulticenter Studies as Topic030212 general & internal medicineProspective StudiesEuropean unionTiotropium BromideAdrenergic beta-2 Receptor Agonistsmedia_commonCOPDbiologybusiness.industryInhalerOlodaterolGeneral MedicineLamamedicine.diseasebiology.organism_classificationLAMA/LABA/ICShumanitiesObstructive lung diseaseBenzoxazinesBronchodilator AgentsRegimen030228 respiratory systemchemistrytriple therapyDrug Therapy Combinationbusinesshormones hormone substitutes and hormone antagonistsInternational Journal of Chronic Obstructive Pulmonary Disease
researchProduct